和乳腺癌狹路相逢5

對於癌症病人，我覺得你一定要檢視你自己的生活方式，但並不是說改變了生活方式就一定有用，還是得看情況，該手術還是得手術，該放化療的還是要放化療。如果應該手術，千萬不要拖延。

我其實特別幸運，因為我及時去做了檢測，在癌細胞隻有1.1毫米時就發現了，而且因為癌細胞不太活躍，拖一陣子也還行。其實我的癌細胞自檢是摸不出的，就算是mammogram的片子，也得要有經驗的醫生才能看出。我真的是很幸運，在對的時間碰見對的醫生，做了對的選擇。

另外，自檢很重要，特別是對於發展快的癌細胞，真的可以摸出來。

下麵附上我的病理檢驗結果：

Right breast mass at 10 o'clock, N5, MRI-guided core biopsy:
A small focus (1.1 mm on glass slides) of invasive carcinoma focally
identified with the following features:
Histologic type: Ductal, no special type.
Histologic grade (Nottingham histologic score): Intermediate grade, 2 of
3, (score 6 of 9).
Tubule formation: Poor, 3 of 3.
Nuclear grade: Intermediate, 2 of 3.
Mitotic rate: Low, 1 of 3.
Lymph-vascular invasion: Not identified.
Ductal carcinoma in situ (DCIS): Present.
Architectural pattern: Solid and cribriform with involvement of lobules.
Nuclear grade: Intermediate.
Necrosis: Not identified.
Associated calcifications: Present.
Additional findings:
Focal flat epithelial atypia and atypical ductal hyperplasia (ADH).
Dense stromal fibrosis and pseudoangiomatous stromal hyperplasia (PASH
).

Immunohistochemical studies for estrogen/progesterone receptor
expression, HER-2/neu overexpression and proliferation index
determination (Ki-67) will be performed and reported in an addendum.

DIAGNOSIS COMMENT:
This right breast mass at 10 o'clock MRI-guided core biopsy
predominantly shows foci of ductal carcinoma in situ (DCIS) with
background stromal fibrosis. A small focus of invasive ductal carcinoma
is focally identified adjacent to DCIS, which measures up to 1.1 mm on
glass slides.

SUMMARY OF PREDICTIVE/PROGNOSTIC MARKERS:
Estrogen Receptor Status: Positive (99% with strong nuclear staining)
Progesterone Receptor Status: Positive (99% with strong nuclear
staining)
HER2 (by immunohistochemistry): Negative (score of 0)
HER2 (by in situ hybridization): Not performed
Proliferation Index (Ki-67): 6%